EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+2.08%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.03%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
103
New
19
Increased
15
Reduced
30
Closed
24
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$32M |
| 2 |
Community Health Systems
CYH
|
$21.9M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$17.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$71.3M |
| 2 |
GSK
GSK
|
$30.3M |
| 3 |
TG Therapeutics
TGTX
|
$26.9M |
| 4 |
Elevance Health
ELV
|
$20.5M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$17.2M |
Sector Composition
| 1 | Healthcare | 90.41% |
| 2 | Industrials | 1.59% |
| 3 | Financials | 0.07% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Intuitive Surgical
ISRG
$158B
| $2.38M | 0.16% |
2,583
| – | – |
|
52
Agilent Technologies
A
$35.5B
| $2.26M | 0.15% |
15,261
| – | – |
|
53
HealthStream
HSTM
$832M
| $2.17M | 0.14% |
+77,812
| New | +$2.17M |
|
54
Ocular Therapeutix
OCUL
$2.25B
| $2.13M | 0.14% |
+150,000
| New | +$2.13M |
|
55
Humacyte
HUMA
$231M
| $2.09M | 0.14% |
205,026
-34,000
| -14% | -$346K |
|
56
HCA Healthcare
HCA
$95.4B
| $1.72M | 0.11% |
8,314
-77,095
| -90% | -$15.9M |
|
57
Seres Therapeutics
MCRB
$162M
| $1.42M | 0.09% |
59,560
-155,716
| -72% | -$3.71M |
|
58
IQVIA
IQV
$31.4B
| $1.38M | 0.09% |
5,712
-209
| -4% | -$50.6K |
|
|
TLGT
59
DELISTED
Teligent, Inc
TLGT
| $1.34M | 0.09% |
2,500,260
| – | – |
|
60
Immunovant
IMVT
$2.91B
| $1.16M | 0.08% |
110,183
-120,000
| -52% | -$1.27M |
|
61
Natera
NTRA
$23B
| $1.06M | 0.07% |
9,314
-48,386
| -84% | -$5.49M |
|
62
Lexicon Pharmaceuticals
LXRX
$392M
| $1.05M | 0.07% |
229,289
-181,304
| -44% | -$832K |
|
|
FSTX
63
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $859K | 0.06% |
+100,000
| New | +$859K |
|
|
HSKA
64
DELISTED
Heska Corp
HSKA
| $784K | 0.05% |
3,412
-7,628
| -69% | -$1.75M |
|
65
The Ensign Group
ENSG
$9.9B
| $778K | 0.05% |
8,973
-19,910
| -69% | -$1.73M |
|
66
GoHealth
GOCO
$77.4M
| $772K | 0.05% |
68,899
| – | – |
|
67
Repligen
RGEN
$6.54B
| $737K | 0.05% |
3,692
+2,264
| +159% | +$452K |
|
68
Cross Country Healthcare
CCRN
$420M
| $509K | 0.03% |
+30,810
| New | +$509K |
|
69
Guardant Health
GH
$8.11B
| $225K | 0.02% |
1,809
-38,438
| -96% | -$4.77M |
|
|
BHVN
70
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-242,172
| Closed | -$16.6M |
|
|
FPRX
71
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-93,280
| Closed | -$3.51M |
|
|
LMNX
72
DELISTED
Luminex Corp
LMNX
| – | – |
-135,471
| Closed | -$4.33M |
|
|
ALXN
73
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-465,983
| Closed | -$71.3M |
|
|
GBT
74
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
0
| – | – |
|
|
CFMS
75
DELISTED
Conformis, Inc. Common Stock
CFMS
| – | – |
-1,541,978
| Closed | -$1.53M |
|